These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31797395)

  • 1. Population Pharmacokinetic-Pharmacodynamic Modeling for Propofol Anesthesia Guided by the Bispectral Index (BIS).
    Araújo AM; Machado H; de Pinho PG; Soares-da-Silva P; Falcão A
    J Clin Pharmacol; 2020 May; 60(5):617-628. PubMed ID: 31797395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of propofol target-controlled infusion models in the obese: pharmacokinetic and pharmacodynamic analysis.
    Cortínez LI; De la Fuente N; Eleveld DJ; Oliveros A; Crovari F; Sepulveda P; Ibacache M; Solari S
    Anesth Analg; 2014 Aug; 119(2):302-310. PubMed ID: 24977639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetic-pharmacodynamic modeling and dosing simulation of propofol maintenance anesthesia in severely obese adolescents.
    Chidambaran V; Venkatasubramanian R; Sadhasivam S; Esslinger H; Cox S; Diepstraten J; Fukuda T; Inge T; Knibbe CAJ; Vinks AA
    Paediatr Anaesth; 2015 Sep; 25(9):911-923. PubMed ID: 25975390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic-pharmacodynamic model for propofol for broad application in anaesthesia and sedation.
    Eleveld DJ; Colin P; Absalom AR; Struys MMRF
    Br J Anaesth; 2018 May; 120(5):942-959. PubMed ID: 29661412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect-Site Target-Controlled Infusion in the Obese: Model Derivation and Performance Assessment.
    Cortínez LI; Sepúlveda P; Rolle A; Cottin P; Guerrini A; Anderson BJ
    Anesth Analg; 2018 Oct; 127(4):865-872. PubMed ID: 29401079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetic-pharmacodynamic model of propofol in adolescents undergoing scoliosis surgery with intraoperative wake-up test: a study using Bispectral index and composite auditory evoked potentials as pharmacodynamic endpoints.
    Blussé van Oud-Alblas HJ; Brill MJE; Peeters MYM; Tibboel D; Danhof M; Knibbe CAJ
    BMC Anesthesiol; 2019 Jan; 19(1):15. PubMed ID: 30669968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetic and pharmacodynamic model of propofol externally validated in Korean elderly subjects.
    Kim KM; Choi BM; Noh GJ
    J Pharmacokinet Pharmacodyn; 2023 Apr; 50(2):97-109. PubMed ID: 36522561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics and pharmacodynamics of propofol in morbidly obese patients.
    van Kralingen S; Diepstraten J; Peeters MY; Deneer VH; van Ramshorst B; Wiezer RJ; van Dongen EP; Danhof M; Knibbe CA
    Clin Pharmacokinet; 2011 Nov; 50(11):739-50. PubMed ID: 21973271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propofol pharmacokinetic and pharmacodynamic profile and its electroencephalographic interaction with remifentanil in children.
    Fuentes R; Cortínez LI; Contreras V; Ibacache M; Anderson BJ
    Paediatr Anaesth; 2018 Dec; 28(12):1078-1086. PubMed ID: 30307663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Population pharmacokinetic modeling and evaluation of propofol from multiple centers].
    Ye HB; Zheng H; Zhang XA; Chi XJ; Chen WY; Xu JG; Li JH; Rui JZ
    Yao Xue Xue Bao; 2010 Dec; 45(12):1550-8. PubMed ID: 21351496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetic analysis of propofol in underweight patients under general anaesthesia.
    Park JH; Choi SM; Park JH; Lee KH; Yun HJ; Lee EK; Choi BM; Noh GJ
    Br J Anaesth; 2018 Sep; 121(3):559-566. PubMed ID: 30115253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age progression from vicenarians (20-29 year) to nonagenarians (90-99 year) among a population pharmacokinetic/pharmacodynamic (PopPk-PD) covariate analysis of propofol-bispectral index (BIS) electroencephalography.
    Dahaba AA; Xiao Z; Zhu X; Dong H; Xiong L; Rehak P; Zelzer S; Wang K; Reibnegger G
    J Pharmacokinet Pharmacodyn; 2020 Apr; 47(2):145-161. PubMed ID: 32100175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective clinical validation of the Eleveld propofol pharmacokinetic-pharmacodynamic model in general anaesthesia.
    Vellinga R; Hannivoort LN; Introna M; Touw DJ; Absalom AR; Eleveld DJ; Struys MMRF
    Br J Anaesth; 2021 Feb; 126(2):386-394. PubMed ID: 33317804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refining Target-Controlled Infusion: An Assessment of Pharmacodynamic Target-Controlled Infusion of Propofol and Remifentanil Using a Response Surface Model of Their Combined Effects on Bispectral Index.
    Short TG; Hannam JA; Laurent S; Campbell D; Misur M; Merry AF; Tam YH
    Anesth Analg; 2016 Jan; 122(1):90-7. PubMed ID: 26683103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal propofol induction dose in morbidly obese patients: A randomized controlled trial comparing the bispectral index and lean body weight scalar.
    Subramani Y; Riad W; Chung F; Wong J
    Can J Anaesth; 2017 May; 64(5):471-479. PubMed ID: 28243855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and Pharmacodynamic Analysis of Alfaxalone Administered as a Bolus Intravenous Injection of Phaxan in a Phase 1 Randomized Trial.
    Goodchild CS; Serrao JM; Sear JW; Anderson BJ
    Anesth Analg; 2020 Mar; 130(3):704-714. PubMed ID: 31124836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of propofol in children undergoing different types of surgeries.
    Bartkowska-Śniatkowska A; Bienert A; Wiczling P; Owczarek M; Rosada-Kurasińska J; Grześkowiak M; Matysiak J; Kokot ZJ; Kaliszan R; Grześkowiak E
    Pharmacol Rep; 2014 Oct; 66(5):821-9. PubMed ID: 25149986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of ear point embedding on plasma and effect site concentrations of propofol-remifentanil in elderly patients after target-controlled induction].
    Zheng X; Wan L; Gao F; Chen J; Tu W
    Zhongguo Zhen Jiu; 2017 Aug; 37(8):869-873. PubMed ID: 29231349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics of propofol in children using three different data analysis approaches.
    Kataria BK; Ved SA; Nicodemus HF; Hoy GR; Lea D; Dubois MY; Mandema JW; Shafer SL
    Anesthesiology; 1994 Jan; 80(1):104-22. PubMed ID: 8291699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the anesthetic depth and bispectral index during propofol sequential target-controlled infusion in dogs.
    Ubiali MLC; Meirelles GP; Vilani JM; da Luz HE; Marangoni S; Rodrigues RB; Vilani RGDC
    Vet World; 2022 Mar; 15(3):537-542. PubMed ID: 35497961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.